- Home
- Industry Reports
- Biotechnology
- Healthcare
- Asia Pacific Cancer Therapy Market- Size, Outlook, Trends and Forecast (2024 – 2032)
Cancer therapies are drugs that are involved in reducing or blocking the growth of cancer by interacting with specific molecules which are responsible for the growth and spread of cancerous cells. Asia Pacific Cancer
Asia Pacific Cancer Therapy Market share:
Asia Pacific Cancer Therapy market is segmented by treatment type, cancer type, targeted cancer therapeutics, application, and geography. On basics of targeted cancer therapeutics, targeted cancer is holding the most significant share due to the various increasing types of cancers and awareness regarding the molecular diagnostics.
Asia Pacific Cancer Therapy Market size:
Therapy Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
The Asia Pacific is occupying the most significant share in the market, especially in targeted therapies demand due to more number of market players and higher patient awareness levels.
Asia Pacific Cancer Therapy Market growth:
The market for Asia Pacific cancer therapy is driven by factors such rise in cancer incidences and access to modern therapeutics, the population of aged people, efficiency and high price manufacturers and innovations and increase in awareness regarding molecular diagnostic techniques that are influencing the market growth.
Asia Pacific Cancer Therapy Market Industrial Analysis:
Asia Pacific Cancer Therapy Market is segmented into treatment type, cancer type, therapeutics, application, and chemotherapy. By treatment type, the market is in surgery, chemotherapy, radiation therapy, targeted therapy, immune therapy, hormonal therapy, hyperthermia and stem cell transplant. By cancer type, the market is in blood therapy, bone cancer, brain cancer, breast cancer, endocrine cancer, eye cancer, gynecologic cancer, head and neck cancer, respiratory and skin cancer. By application, the market is a nasal spray, pills or tablets, skin gel, skin patches, vaginal creams or vaginal tablets and vaginal ring.
Asia Pacific Cancer Therapy Market Outlook:
Asia Pacific Cancer Therapy market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and cancer types. Many industries and firms are trying to develop new technologies and make advancements to improve the market.
Asia Pacific Cancer Therapy Market Trends:
Abbott has completed the acquisition of St.jude Medical, Inc., to develop the company as a leader in medical arena in January 2017.
Genentech and Tanox are trying to collaborate with Novartis to develop and commercialise Xolair and anti-IgE monoclonal antibody.
Asia Pacific Cancer Therapy Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Pfizer
- Sanofi
- Aveo Pharmaceuticals
- GPC Biotech Ag
- Boehringer Ingelheim GmbH
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Treatment Type
6.1 Chemotherapy
6.2 Surgery
6.3 Radiation Therapy
6.4 Immunotherapy
6.5 Targeted Therapy
6.6 Signal Transduction Inhibitors
6.7 Stem Cell Transplant
6.8 Hormonal Therapy
6.9 Apoptosis Inducers
6.10 Others
Chapter 7 Market Segmentation by Cancer Type
7.1 Eye Cancer
7.2 Bone Cancer
7.3 Brain Cancer
7.4 Blood Cancer
7.5 Endocrine Cancer
7.6 Skin Cancer
7.7 Others
Chapter 8 Market Segmentation by Targeted Cancer Therapeutics
8.1 Hormone Therapy
8.2 Targeted Cancer Therapeutics
8.3 Signal Transduction Inhibitors
8.4 Immunotherapies
8.4.1 Monoclonal Antibodies
8.4.1.1 Naked Monoclonal Antibodies
8.4.1.2 Conjugated Monoclonal Antibodies
8.4.1.2.1 Radiolabeled Antibodies
8.4.1.2.2 Chemolabeled Antibodies
8.5 Cancer Vaccines
8.6 Non-Specific Immunotherapies
8.7 Others
Chapter 9 Market Segmentation by Application
9.1 Nasal Spray
9.2 Pills or Tablets
9.3 Skin Gel
9.4 Skin Patches
9.5 Vaginal Ring
9.6 Others
Chapter 10 Market Segmentation by Geography
10.1 Asia Pacific
10.1.1 Introduction
10.1.2 China
10.1.3 Japan
10.1.4 India
10.1.5 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profiles
12.1 AstraZeneca Plc
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Strategic Initiative
12.2 Novartis
12.3 Bayer
12.4 Sanofi
12.5 GlaxoSmithKline Plc
12.6 Hospira Inc.,
12.7 Aveo pharmaceuticals
12.8 Boehringer Ingelheim GmbH
12.9 GPC Biotech Ag
12.10 Chugai Pharmaceutical Co., Ltd.
12.11 OSI Pharmaceuticals, Inc.
12.12 Abbott laboratories
12.13 Genentech Inc.
12.14 Pfizer
Chapter 13 Market Estimates and Forecasting
13.1 Market Estimates and Forecasting 2018-2024(USD Million)
13.1.1 Market Estimation and Forecasting by Treatment Type 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecasting by Cancer Type 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecasting for Targeted Cancer Therapeutics 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
13.1.5 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,003.90 - €6,679.65
- INR: ₹180,387.75 - ₹601,292.51
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,724.45 - £5,748.18
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Cancer therapies are drugs that are involved in reducing or blocking the growth of cancer by interacting with specific molecules which are responsible for the growth and spread of cancerous cells. Asia Pacific Cancer
Asia Pacific Cancer Therapy Market share:
Asia Pacific Cancer Therapy market is segmented by treatment type, cancer type, targeted cancer therapeutics, application, and geography. On basics of targeted cancer therapeutics, targeted cancer is holding the most significant share due to the various increasing types of cancers and awareness regarding the molecular diagnostics.
Asia Pacific Cancer Therapy Market size:
Therapy Market is accounted for USD XX billion in 2017 and expected to grow at a CAGR of X% to reach USD XX billion by 2024.
The Asia Pacific is occupying the most significant share in the market, especially in targeted therapies demand due to more number of market players and higher patient awareness levels.
Asia Pacific Cancer Therapy Market growth:
The market for Asia Pacific cancer therapy is driven by factors such rise in cancer incidences and access to modern therapeutics, the population of aged people, efficiency and high price manufacturers and innovations and increase in awareness regarding molecular diagnostic techniques that are influencing the market growth.
Asia Pacific Cancer Therapy Market Industrial Analysis:
Asia Pacific Cancer Therapy Market is segmented into treatment type, cancer type, therapeutics, application, and chemotherapy. By treatment type, the market is in surgery, chemotherapy, radiation therapy, targeted therapy, immune therapy, hormonal therapy, hyperthermia and stem cell transplant. By cancer type, the market is in blood therapy, bone cancer, brain cancer, breast cancer, endocrine cancer, eye cancer, gynecologic cancer, head and neck cancer, respiratory and skin cancer. By application, the market is a nasal spray, pills or tablets, skin gel, skin patches, vaginal creams or vaginal tablets and vaginal ring.
Asia Pacific Cancer Therapy Market Outlook:
Asia Pacific Cancer Therapy market is expected to grow at a significant rate over the forecast period and is anticipated to perform well due to awareness regarding chronic diseases and cancer types. Many industries and firms are trying to develop new technologies and make advancements to improve the market.
Asia Pacific Cancer Therapy Market Trends:
Abbott has completed the acquisition of St.jude Medical, Inc., to develop the company as a leader in medical arena in January 2017.
Genentech and Tanox are trying to collaborate with Novartis to develop and commercialise Xolair and anti-IgE monoclonal antibody.
Asia Pacific Cancer Therapy Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have complete market analysis through industry value chain analysis, Porter’s five, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions.
- Scrutinizing the revenue generation on Year–On–Year
- Identifying DROC in the current market and their impact in altering the market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the major market players, such as:
- Pfizer
- Sanofi
- Aveo Pharmaceuticals
- GPC Biotech Ag
- Boehringer Ingelheim GmbH
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2 Porter’s Five Analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1 DROC
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
Chapter 5 Market Segmentation Analysis
Chapter 6 Market Segmentation by Treatment Type
6.1 Chemotherapy
6.2 Surgery
6.3 Radiation Therapy
6.4 Immunotherapy
6.5 Targeted Therapy
6.6 Signal Transduction Inhibitors
6.7 Stem Cell Transplant
6.8 Hormonal Therapy
6.9 Apoptosis Inducers
6.10 Others
Chapter 7 Market Segmentation by Cancer Type
7.1 Eye Cancer
7.2 Bone Cancer
7.3 Brain Cancer
7.4 Blood Cancer
7.5 Endocrine Cancer
7.6 Skin Cancer
7.7 Others
Chapter 8 Market Segmentation by Targeted Cancer Therapeutics
8.1 Hormone Therapy
8.2 Targeted Cancer Therapeutics
8.3 Signal Transduction Inhibitors
8.4 Immunotherapies
8.4.1 Monoclonal Antibodies
8.4.1.1 Naked Monoclonal Antibodies
8.4.1.2 Conjugated Monoclonal Antibodies
8.4.1.2.1 Radiolabeled Antibodies
8.4.1.2.2 Chemolabeled Antibodies
8.5 Cancer Vaccines
8.6 Non-Specific Immunotherapies
8.7 Others
Chapter 9 Market Segmentation by Application
9.1 Nasal Spray
9.2 Pills or Tablets
9.3 Skin Gel
9.4 Skin Patches
9.5 Vaginal Ring
9.6 Others
Chapter 10 Market Segmentation by Geography
10.1 Asia Pacific
10.1.1 Introduction
10.1.2 China
10.1.3 Japan
10.1.4 India
10.1.5 Others
Chapter 11 Competitive Landscape
11.1 Mergers & Acquisitions, Joint Ventures, Collaborations, and Agreements
11.2 Market Share Analysis
11.3 Strategies Adopted By Top Companies
Chapter 12 Company Profiles
12.1 AstraZeneca Plc
12.1.1. Company Overview
12.1.2. Financial Performance
12.1.3. Product Benchmarking
12.1.4. Strategic Initiative
12.2 Novartis
12.3 Bayer
12.4 Sanofi
12.5 GlaxoSmithKline Plc
12.6 Hospira Inc.,
12.7 Aveo pharmaceuticals
12.8 Boehringer Ingelheim GmbH
12.9 GPC Biotech Ag
12.10 Chugai Pharmaceutical Co., Ltd.
12.11 OSI Pharmaceuticals, Inc.
12.12 Abbott laboratories
12.13 Genentech Inc.
12.14 Pfizer
Chapter 13 Market Estimates and Forecasting
13.1 Market Estimates and Forecasting 2018-2024(USD Million)
13.1.1 Market Estimation and Forecasting by Treatment Type 2018-2024 (USD Million)
13.1.2 Market Estimates and Forecasting by Cancer Type 2018-2024 (USD Million)
13.1.3 Market Estimates and Forecasting for Targeted Cancer Therapeutics 2018-2024 (USD Million)
13.1.4 Market Estimates and Forecasting by Application 2018-2024 (USD Million)
13.1.5 Market Estimates and Forecasting by Geography 2018-2024 (USD Million)
Chapter 14 Market Insights
14.1 Insights of Industry Experts
14.2 Analyst Opinion (Market Understanding)
14.3 Investment Opportunities
Chapter 15 Appendix
15.1 List of Tables
15.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.